These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 27052349)

  • 1. Evidence for a critical role of the sympathetic nervous system in hypertension.
    Grassi G; Ram VS
    J Am Soc Hypertens; 2016 May; 10(5):457-66. PubMed ID: 27052349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sympathetic nervous system: role in hypertension and in chronic kidney disease.
    Grassi G; Bertoli S; Seravalle G
    Curr Opin Nephrol Hypertens; 2012 Jan; 21(1):46-51. PubMed ID: 22080859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sympathetic nervous system and new nonpharmacologic approaches to treating hypertension: a focus on renal denervation.
    Grassi G; Seravalle G; Brambilla G; Mancia G
    Can J Cardiol; 2012 May; 28(3):311-7. PubMed ID: 22244774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marked sympathetic activation and baroreflex dysfunction in true resistant hypertension.
    Grassi G; Seravalle G; Brambilla G; Pini C; Alimento M; Facchetti R; Spaziani D; Cuspidi C; Mancia G
    Int J Cardiol; 2014 Dec; 177(3):1020-5. PubMed ID: 25449517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathoinhibitory Effect of Radiofrequency Renal Denervation in Spontaneously Hypertensive Rats With Established Hypertension.
    Gao J; Kerut EK; Smart F; Katsurada A; Seth D; Navar LG; Kapusta DR
    Am J Hypertens; 2016 Dec; 29(12):1394-1401. PubMed ID: 27538721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The future of interventional management of hypertension: threats and opportunities.
    Briasoulis A; Bakris G
    Curr Vasc Pharmacol; 2014 Jan; 12(1):69-76. PubMed ID: 23905592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New approaches in the treatment of hypertension.
    Oparil S; Schmieder RE
    Circ Res; 2015 Mar; 116(6):1074-95. PubMed ID: 25767291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The sympathetic nervous system and blood pressure in humans: implications for hypertension.
    Fisher JP; Paton JF
    J Hum Hypertens; 2012 Aug; 26(8):463-75. PubMed ID: 21734720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What we need to know about renal nerve ablation for treatment of hypertension and other states of sympathetic overactivity.
    Schlaich MP
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1267-F1270. PubMed ID: 27630063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathetic and baroreflex cardiovascular control in hypertension-related left ventricular dysfunction.
    Grassi G; Seravalle G; Quarti-Trevano F; Dell'Oro R; Arenare F; Spaziani D; Mancia G
    Hypertension; 2009 Feb; 53(2):205-9. PubMed ID: 19124679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 'neuroadrenergic hypothesis' in hypertension: current evidence.
    Grassi G; Seravalle G; Quarti-Trevano F
    Exp Physiol; 2010 May; 95(5):581-6. PubMed ID: 20008032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The human sympathetic nervous system: its relevance in hypertension and heart failure.
    Parati G; Esler M
    Eur Heart J; 2012 May; 33(9):1058-66. PubMed ID: 22507981
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Carotid stimulation studies support a prominent role for the sympathetic nervous system.
    Wehrwein EA
    J Appl Physiol (1985); 2010 Dec; 109(6):2009. PubMed ID: 21188821
    [No Abstract]   [Full Text] [Related]  

  • 14. Similarities and differences between renal sympathetic denervation and carotid baroreceptor stimulation.
    Grassi G; Seravalle G; Brambilla G; Cesana F; Giannattasio C; Mancia G
    Curr Vasc Pharmacol; 2014 Jan; 12(1):63-8. PubMed ID: 23905595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comments on Point:Counterpoint: The dominant contributor to systemic hypertension: Chronic activation of the sympathetic nervous system vs. Activation of the intrarenal renin-angiotensin system. Activation of the sympathetic nervous system is the dominant contributor to systemic hypertension.
    Negrao CE; Negrao MV
    J Appl Physiol (1985); 2010 Dec; 109(6):2006. PubMed ID: 21188817
    [No Abstract]   [Full Text] [Related]  

  • 16. Renal Denervation-Ready for Prime Time!? The Steep SPYRAL Stairs to RADIANCE in Hypertension Treatment.
    Schlaich MP; Kiuchi MG; Esler MD
    Hypertension; 2018 Aug; 72(2):287-290. PubMed ID: 29941510
    [No Abstract]   [Full Text] [Related]  

  • 17. The central sympathetic nervous system in hypertension.
    Mancia G; Grassi G
    Handb Clin Neurol; 2013; 117():329-35. PubMed ID: 24095136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sympathetic and baroreflex function in hypertension: implications for current and new drugs.
    Grassi G
    Curr Pharm Des; 2004; 10(29):3579-89. PubMed ID: 15579055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the sympathetic nervous system in human hypertension.
    Grassi G
    J Hypertens; 1998 Dec; 16(12 Pt 2):1979-87. PubMed ID: 9886886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives.
    Grassi G
    Hypertension; 2009 Oct; 54(4):690-7. PubMed ID: 19720958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.